Single‐agent lenalidomide is active in patients with relapsed or refractory aggressive non‐Hodgkin lymphoma who received prior stem cell transplantation
暂无分享,去创建一个
I. Lossos | J. Vose | M. Czuczman | T. Habermann | P. Zinzani | C. Reeder | T. Witzig | J. Tuscano | D. Pietronigro | Ju Li | Myron S. Czuczman